COVID-19 IgG/IgM Rapid Tests
Essentials of working
The 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of IgG and IgM antibodies to 2019-nCoV in whole blood, serum or plasma specimen. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in IgG test line region. During testing, the specimen reacts with 2019-nCoV antigen-coated particles in the test cassette. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in IgG test line region, if the specimen contains IgG antibodies to 2019-nCoV. A colored line will appear in IgG test line region as a result of this. Similarly, anti-human IgM is coated in IgM test line region and if specimen contains IgM antibodies to 2019-nCoV, the conjugate-specimen complex reacts with anti-human IgM. A colored line appears in IgM test line region as a result.
The 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) was compared with a leading commercial PCR; the results show that 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) has a high ability of measuring the proportion of actual positives, sensitivity, and ability of measuring the proportion of actual negatives, namely specificity.
What is in the Package?
The test are packed in the boxes containing 50 pieces of test’s kits includeing cassettes along with needles for drawing the samples and reactions catalyst.
Why is it worth to trust us?
The Novazym’s COVID-19 rapid test had been registered as the solution to identify the SARS-COV-2 viruses’ presence, by the polish institute URPL. Clinical studies were performed with the criteria corresponding to international standards, including ISO/IEC 17025 and ISO 15189. Results of this studies are available to download :